• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

弥散加权成像(DWI)和脊柱关节病研究协作组(SPARCC)评分评估早期强直性脊柱炎的疗效。

DWI and SPARCC scoring assess curative effect of early ankylosing spondylitis.

作者信息

Qin Jian, Zhu Jianzhong, Zhang Yue, Li Changqin

机构信息

, Division of Radiology, Taishan Medical School Affiliated Hospital, Taian, Shandong Province 271000, China.

出版信息

Open Med (Wars). 2016 Mar 10;11(1):52-58. doi: 10.1515/med-2016-0011. eCollection 2016.

DOI:10.1515/med-2016-0011
PMID:28352767
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5329798/
Abstract

BACKGROUND

To investigate the magnetic diffusion weighted imaging (DWI) sequence and Spondyloarthritis Research Consortium of Canada (SPARCC) scoring in assessing curative effect of combined treatment of Chinese and Western medicine for early ankylosing spondylitis (AS).

METHODS

48 cases diagnosed as early AS and treated with Chinese and Western medicine were included in the study. Magnetic routine and DWI sequence scanning image were performed to obtain the mean apparent diffusion coefficient (ADC) value of sub-articular surface bone marrow. Combined with SPARCC scoring, statistical analysis was conducted to compare the difference with the information obtained in the previous study.

RESULTS

The mean ADC value in the sub-articular surface bone marrow of patients after clinical treatment: (4.34±0.55)×10-4mm2/s in ilium and (3.96±0.23)×10-4mm2/s in sacrum, which were both significantly lower than that before treatment (p< 0.05). There was highly positive correlation between mean ADC value and SPARCC scoring (P<0.05). The regression relationship could be demonstrated as Y=-64.420+21.262X(Y: SPARCC scoring value; X: mean ADC value).

CONCLUSIONS

Magnetic DWI and SPARCC scoring could be applied in accessing AS inflammation activity changes and in reflect of curative effect of early AS patients as well as in providing reliable radiologist evidence for clinical therapeutic efficacy.

摘要

背景

探讨磁共振扩散加权成像(DWI)序列及加拿大脊柱关节炎研究联盟(SPARCC)评分在评估中西医结合治疗早期强直性脊柱炎(AS)疗效中的应用。

方法

纳入48例确诊为早期AS且接受中西医结合治疗的患者。行磁共振常规及DWI序列扫描成像,获取关节面下骨髓的平均表观扩散系数(ADC)值。结合SPARCC评分进行统计分析,与前期研究所得信息比较差异。

结果

临床治疗后患者关节面下骨髓平均ADC值:髂骨为(4.34±0.55)×10⁻⁴mm²/s,骶骨为(3.96±0.23)×10⁻⁴mm²/s,均显著低于治疗前(p<0.05)。平均ADC值与SPARCC评分呈高度正相关(P<0.05)。回归关系可表示为Y=-64.420+21.262X(Y:SPARCC评分值;X:平均ADC值)。

结论

磁共振DWI及SPARCC评分可用于评估AS炎症活动度变化,反映早期AS患者的疗效,为临床治疗效果提供可靠的影像学依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0d1/5329798/9cd9e8d3daba/j_med-2016-0011_fig_004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0d1/5329798/95b8a677ff23/j_med-2016-0011_fig_001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0d1/5329798/2b6727a1a035/j_med-2016-0011_fig_002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0d1/5329798/4fc5412acc53/j_med-2016-0011_fig_003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0d1/5329798/9cd9e8d3daba/j_med-2016-0011_fig_004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0d1/5329798/95b8a677ff23/j_med-2016-0011_fig_001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0d1/5329798/2b6727a1a035/j_med-2016-0011_fig_002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0d1/5329798/4fc5412acc53/j_med-2016-0011_fig_003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0d1/5329798/9cd9e8d3daba/j_med-2016-0011_fig_004.jpg

相似文献

1
DWI and SPARCC scoring assess curative effect of early ankylosing spondylitis.弥散加权成像(DWI)和脊柱关节病研究协作组(SPARCC)评分评估早期强直性脊柱炎的疗效。
Open Med (Wars). 2016 Mar 10;11(1):52-58. doi: 10.1515/med-2016-0011. eCollection 2016.
2
Whole-lesion ADC histogram analysis and the spondyloarthritis research consortium of canada (SPARCC) MRI index in evaluating the disease activity of ankylosing spondylitis.全病灶 ADC 直方图分析与加拿大脊柱关节炎研究协会(SPARCC)MRI 指数评估强直性脊柱炎的疾病活动度。
J Magn Reson Imaging. 2019 Jul;50(1):114-126. doi: 10.1002/jmri.26568. Epub 2018 Dec 16.
3
[Application of magnetic resonance diffusion weighted imaging in early ankylosing spondylitis].磁共振扩散加权成像在早期强直性脊柱炎中的应用
Zhonghua Yi Xue Za Zhi. 2013 Mar 19;93(11):811-5.
4
Role of Diffusion-weighted and Contrast-enhanced Magnetic Resonance Imaging in Differentiating Activity of Ankylosing Spondylitis.扩散加权和对比增强磁共振成像在区分强直性脊柱炎活动度中的作用
Chin Med J (Engl). 2017 Jun 5;130(11):1303-1308. doi: 10.4103/0366-6999.206359.
5
Comparative analysis of the diagnostic values of T2 mapping and diffusion-weighted imaging for sacroiliitis in ankylosing spondylitis.强直性脊柱炎中骶髂关节炎的T2映射和扩散加权成像诊断价值的比较分析
Skeletal Radiol. 2020 Oct;49(10):1597-1606. doi: 10.1007/s00256-020-03442-8. Epub 2020 May 8.
6
Role of diffusion-weighted imaging in early ankylosing spondylitis.弥散加权成像在早期强直性脊柱炎中的作用。
Chin Med J (Engl). 2013 Feb;126(4):668-73.
7
ASDAS is associated with both the extent and intensity of DW-MRI spinal inflammation in active axial spondyloarthritis.ASDAS 与活动性轴性脊柱关节炎的 DW-MRI 脊柱炎症的程度和强度均相关。
RMD Open. 2019 Aug 6;5(2):e001008. doi: 10.1136/rmdopen-2019-001008. eCollection 2019.
8
Diffusion-weighted Imaging Is a Sensitive and Specific Magnetic Resonance Sequence in the Diagnosis of Ankylosing Spondylitis.弥散加权成像在强直性脊柱炎的诊断中具有较高的敏感性和特异性。
J Rheumatol. 2018 Jun;45(6):771-778. doi: 10.3899/jrheum.170312. Epub 2018 Feb 15.
9
Clinical application of diffusion-weighted imaging and dynamic contrast-enhanced MRI in assessing the clinical curative effect of early ankylosing spondylitis.扩散加权成像及动态对比增强磁共振成像在评估早期强直性脊柱炎临床疗效中的临床应用
Medicine (Baltimore). 2019 May;98(20):e15227. doi: 10.1097/MD.0000000000015227.
10
Value of diffusion-weighted magnetic resonance imaging in early diagnosis of ankylosing spondylitis.弥散加权磁共振成像在强直性脊柱炎早期诊断中的价值。
Rheumatol Int. 2012 Dec;32(12):4005-13. doi: 10.1007/s00296-011-2333-9. Epub 2012 Jan 3.

引用本文的文献

1
Multi-b-values-fitting readout-segmentation of long variable echo-trains diffusion-weighted imaging (RESOLVE DWI) in evaluation of disease activity and curative effect of axial spondyloarthritis (axSpA).多 b 值拟合读出分段长回波链扩散加权成像(RESOLVE DWI)在评价中轴型脊柱关节炎(axSpA)的疾病活动度和疗效中的应用。
Front Immunol. 2023 Jul 3;14:1136925. doi: 10.3389/fimmu.2023.1136925. eCollection 2023.
2
The evaluation of bone marrow edema in sacroiliac joint in patients with ankylosing spondylitis using magnetic resonance imaging Dixon sequence.磁共振 Dixon 序列评估强直性脊柱炎患者骶髂关节骨髓水肿。
BMC Musculoskelet Disord. 2021 Nov 1;22(1):919. doi: 10.1186/s12891-021-04716-5.
3

本文引用的文献

1
A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS study.一项比较 CT-P13 和创新型英夫利昔单抗在强直性脊柱炎患者中的药代动力学、安全性和疗效的随机、双盲、多中心、平行组、前瞻性研究:PLANETAS 研究。
Ann Rheum Dis. 2013 Oct;72(10):1605-12. doi: 10.1136/annrheumdis-2012-203091. Epub 2013 May 16.
2
Thalidomide reduces recurrence of ankylosing spondylitis in patients following discontinuation of etanercept.沙利度胺可降低依那西普停药后强直性脊柱炎患者的复发率。
Rheumatol Int. 2013 Jun;33(6):1409-13. doi: 10.1007/s00296-012-2571-5. Epub 2012 Nov 11.
3
Validation of assessment methods for the apparent diffusion coefficient in a clinical trial of axial spondyloarthritis patients treated with golimumab.
戈利木单抗治疗中轴型脊柱关节炎患者临床试验中表观扩散系数评估方法的验证
Eur J Radiol Open. 2020 Nov 5;7:100285. doi: 10.1016/j.ejro.2020.100285. eCollection 2020.
4
A quick decrease of bone marrow edema in sacroiliac joint could be served as a novel marker for dose tapering of etanercept in ankylosing spondylitis patients.骶髂关节骨髓水肿的快速减轻可作为强直性脊柱炎患者依那西普减量的新指标。
Medicine (Baltimore). 2019 Mar;98(11):e14620. doi: 10.1097/MD.0000000000014620.
Defining the Minimally Important Change for the SpondyloArthritis Research Consortium of Canada Spine and Sacroiliac Joint Magnetic Resonance Imaging Indices for Ankylosing Spondylitis.
定义加拿大脊柱关节炎研究联合会脊柱和骶髂关节磁共振成像指数用于强直性脊柱炎的最小重要变化。
J Rheumatol. 2012 Aug;39(8):1666-74. doi: 10.3899/jrheum.120131. Epub 2012 Jul 1.
4
Influence of methotrexate on infliximab pharmacokinetics and pharmacodynamics in ankylosing spondylitis.甲氨蝶呤对强直性脊柱炎患者英夫利昔单抗药代动力学和药效学的影响。
Br J Clin Pharmacol. 2012 Jan;73(1):55-65. doi: 10.1111/j.1365-2125.2011.04050.x.
5
Efficacy of etanercept on rheumatic signs and pulmonary function tests in advanced ankylosing spondylitis: results of a randomised double-blind placebo-controlled study (SPINE).依那西普治疗晚期强直性脊柱炎的风湿学指标和肺功能试验的疗效:一项随机、双盲、安慰剂对照研究(脊柱)的结果。
Ann Rheum Dis. 2011 May;70(5):799-804. doi: 10.1136/ard.2010.139261. Epub 2011 Feb 13.
6
Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores.强直性脊柱炎疾病活动评分 (ASDAS):确定疾病活动状态和改善评分的临界值。
Ann Rheum Dis. 2011 Jan;70(1):47-53. doi: 10.1136/ard.2010.138594. Epub 2010 Nov 10.
7
Role for imaging studies in ankylosing spondylitis.影像学检查在强直性脊柱炎中的作用。
Joint Bone Spine. 2011 Mar;78(2):138-43. doi: 10.1016/j.jbspin.2010.07.008. Epub 2010 Sep 17.
8
Report of 12 cases of ankylosing spondylitis patients treated with Tripterygium wilfordii.雷公藤治疗强直性脊柱炎 12 例报告。
Clin Rheumatol. 2010 Sep;29(9):1067-72. doi: 10.1007/s10067-010-1497-0. Epub 2010 Jun 19.
9
Cost effectiveness of etoricoxib versus celecoxib and non-selective NSAIDS in the treatment of ankylosing spondylitis.依托考昔对比塞来昔布和非选择性 NSAIDs 在治疗强直性脊柱炎中的成本效果。
Pharmacoeconomics. 2010;28(4):323-44. doi: 10.2165/11314690-000000000-00000.
10
Whole-body MR imaging in psoriatic arthritis: additional value for therapeutic decision making.全身磁共振成像在银屑病关节炎中的应用:对治疗决策的附加价值。
Eur J Radiol. 2011 Jan;77(1):149-55. doi: 10.1016/j.ejrad.2009.06.020. Epub 2009 Jul 24.